Today: 24 April 2026
P&G Beats Wall Street, Then Warns of a $150 Million Cost Hit
24 April 2026
2 mins read

P&G Beats Wall Street, Then Warns of a $150 Million Cost Hit

April 24, 2026, Cincinnati—08:11 EDT.

Procter & Gamble topped Wall Street’s profit and sales forecasts Friday, lifted by stronger demand for its beauty and hair-care lines. Still, the company behind Tide and Olay flagged rising commodity costs, linked to the Middle East conflict, as a drag on earnings for the remainder of its fiscal year.

This update lands at a tricky moment for the consumer goods group, with volume growth finally returning just as oil, packaging, and freight expenses start to bite. P&G is now guiding fiscal 2026 earnings toward the low end of its stated range, though it hasn’t changed the range itself.

P&G posted net sales of $21.2 billion for its fiscal third quarter, a 7% increase from last year. Core earnings per share came in at $1.59, up 3%, edging past the $1.56 consensus from Reuters. Revenue cleared analysts’ expectations too, beating the $20.50 billion figure from the LSEG survey.

Organic sales climbed 3%, leaving out the effects of currency swings, deals, or asset sales. That number outpaced every analyst forecast tracked by Bloomberg, notching P&G’s biggest organic gain in over a year.

It wasn’t only about price this quarter. P&G reported a 2% bump in organic volume, with beauty leading—volumes there climbed 5%. Beauty organic sales moved up 7%, thanks to hair care, personal care, and skin care. As for grooming and health-care, volumes slipped.

Chief Executive Shailesh Jejurikar described the results as a “solid acceleration” in top-line growth, adding that P&G plans to boost investment even as it navigates a “challenging geopolitical and economic environment.” Every one of the company’s 10 product categories posted organic sales growth for the quarter, according to Procter & Gamble. Procter Gamble

The cost side is proving tough. P&G projects an after-tax hit of around $150 million from commodities in fiscal 2026, with tariff expenses expected to tack on another $400 million. Offsetting some of that: a $200 million lift from foreign exchange. All in, management figures these factors will shave 25 cents off per-share earnings.

Procter & Gamble CFO Andre Schulten told CNBC that $100 per barrel oil would hit the company with an estimated $1 billion after-tax cost for the year, Reuters reported in a MarketScreener news flash.

Margins took a hit. P&G’s reported gross margin dropped 1.5 percentage points year over year, and core gross margin slipped by 1 point—pressured by mix, reinvestment, tariffs, and higher commodity costs. Productivity gains and price hikes cushioned some of the blow, the company noted.

P&G shares ticked up ahead of the bell after the report landed. Reuters reported a roughly 2% gain in premarket action, suggesting investors were shrugging off the cost warning—at least for now—thanks to sales and volume figures that cleared a low bar.

Peers aren’t seeing the same trends. According to Reuters, Nestle flagged higher costs tied to the Strait of Hormuz blockade. Over at L’Oreal, sales of premium hair care and fragrances stayed solid in North America and Europe. And Beiersdorf, for its part, hasn’t ruled out price hikes if commodity costs push higher.

The downside risk isn’t minor. A P&G spokesperson told Reuters that if the conflict continues, cost pressures could ramp up as early as the first quarter of fiscal 2027. The company, notably, hasn’t provided any guidance for fiscal 2027. When it comes to tariff refunds, the timeline is still unclear.

P&G left its fiscal 2026 sales growth projection unchanged at 1% to 5% and stuck to the same core EPS range, $6.83 to $7.09. The company is also holding steady on plans for about $10 billion in dividends and around $5 billion in buybacks this fiscal year.

Stock Market Today

  • Israel-Lebanon ceasefire, Microsoft buyouts, and Regeneron drug discounts highlight markets
    April 24, 2026, 9:12 AM EDT. Stock futures mixed after major indexes fall. An extended Israel-Lebanon ceasefire and hopes of U.S.-Iran peace talks lower crude oil prices. President Trump orders U.S. Navy to target boats laying mines in the Strait of Hormuz, where a naval standoff continues. Microsoft launches voluntary buyouts for 7% of U.S. staff, marking a first, alongside Meta's 10% job cuts and Nike trimming 1,400 mainly tech roles. Regeneron joins pharmaceutical companies reducing drug prices after White House deals, offering discounts and free gene therapy for hearing loss, reflecting ongoing U.S. efforts to ease healthcare costs.

Latest article

Amazon-Backed X-Energy’s $1 Billion IPO Puts Nuclear Power Back in the AI Spotlight

Amazon-Backed X-Energy’s $1 Billion IPO Puts Nuclear Power Back in the AI Spotlight

24 April 2026
X-energy raised about $1.02 billion in an upsized IPO, pricing 44.25 million shares at $23 each, 21% above the marketed range. Trading under “XE” on Nasdaq was set to begin Friday. The company has not yet delivered a commercial Xe-100 reactor or reached final investment decisions. Amazon anchored a prior $500 million financing round for X-energy.
Regeneron Stock Is Back In Focus: Why Wall Street Sees More Upside After Trump Deal

Regeneron Stock Is Back In Focus: Why Wall Street Sees More Upside After Trump Deal

24 April 2026
Regeneron shares rose 2.6% Thursday after the company announced a U.S. drug-pricing agreement and said it would offer its new Otarmeni gene therapy free in the U.S. The stock closed at $766.02, up for the week and month but down 1.3% year to date. Raymond James and Cantor Fitzgerald reiterated bullish ratings and high price targets ahead of first-quarter results due April 29.
P&G Beats Wall Street, Then Warns of a $150 Million Cost Hit

P&G Beats Wall Street, Then Warns of a $150 Million Cost Hit

24 April 2026
Procter & Gamble reported fiscal Q3 net sales of $21.2 billion, up 7%, and core earnings per share of $1.59, beating estimates. Organic sales rose 3%, the strongest in over a year, with beauty volumes up 5%. The company warned higher commodity and tariff costs tied to Middle East conflict will weigh on fiscal 2026 earnings, now expected at the low end of its range. P&G shares rose 2% in premarket trading.
IREN Stock Faces May 7 Test as AI Data Center Pivot, Microsoft Deal and $6 Billion Share-Sale Risk Collide
Previous Story

IREN Stock Faces May 7 Test as AI Data Center Pivot, Microsoft Deal and $6 Billion Share-Sale Risk Collide

Regeneron Stock Is Back In Focus: Why Wall Street Sees More Upside After Trump Deal
Next Story

Regeneron Stock Is Back In Focus: Why Wall Street Sees More Upside After Trump Deal

Go toTop